Nitroreductase-responsive gated mesoporous silica nanocarriers for hypoxia-targeted drug delivery
Authors:
- Ramón Martínez-MáñezRMRamón Martínez-Máñez
- M. Carmen MontesinosMMM. Carmen Montesinos
- Pablo GaviñaPablo Gaviña
Open Access
- 13 February 2025
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 672, 125326
Abstract
No abstract availableKeywords
Funding Information
- Ministerio de Ciencia e Innovación (PID2021-126304OB-C43, PID2021-126304OB-C42)
- European Regional Development Fund
- Universitat de València
- Generalitat of Valencia (CIAICO/2022/146, CIPROM/2021/007)
This publication has 29 references indexed in Scilit:
- Fe-doped biodegradable dendritic mesoporous silica nanoparticles for starvation therapy and photothermal-enhanced cascade catalysis in tumor therapyJournal of Colloid and Interface Science, 2024
- Current trends in smart mesoporous silica-based nanovehicles for photoactivated cancer therapyJournal of Controlled Release, 2021
- Hypoxia-responsive nanoparticles for tumor-targeted drug deliveryCancer Letters, 2020
- Nitroreductase‐Mediated Release of Inhibitors of Lysine‐Specific Demethylase 1 (LSD1) from Prodrugs in Transfected Acute Myeloid Leukaemia CellsChemBioChem, 2020
- Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date reviewJournal of Controlled Release, 2020
- Hypoxia-Induced Resistance to Chemotherapy in Cancer2019
- Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug deliveryBiomaterials, 2014
- Hypoxia in cancer: significance and impact on clinical outcomeCancer and Metastasis Reviews, 2007
- Synthesis and Characterization of Functionalized MCM-41 with Copper– and Manganese–Phenanthroline ComplexesJournal of Solid State Chemistry, 2000
- Comparisons of two in vitro cytotoxicity assays—The neutral red (NR) and tetrazolium MTT testsToxicology in Vitro, 1988